- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-CD37 targeted immunotherapy of B-Cell malignancies
Authors
Keywords
-
Journal
BIOTECHNOLOGY LETTERS
Volume 40, Issue 11-12, Pages 1459-1466
Publisher
Springer Nature America, Inc
Online
2018-10-06
DOI
10.1007/s10529-018-2612-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Affinity maturation and characterization of the ofatumumab monoclonal antibody
- (2018) Zahra Payandeh et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Assessment of CD37 B-cell antigen and cell-of-origin significantly improves risk prediction in diffuse large B-cell lymphoma
- (2016) Z. Y. Xu-Monette et al. BLOOD
- Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment
- (2016) S Betrian et al. Blood Cancer Journal
- AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML
- (2015) D. S. Pereira et al. MOLECULAR CANCER THERAPEUTICS
- Anti-CD37 antibodies for chronic lymphocytic leukemia
- (2014) Tadeusz Robak et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patients
- (2014) Ajay K. Gopal et al. INVESTIGATIONAL NEW DRUGS
- Biopharmaceutical benchmarks 2014
- (2014) Gary Walsh NATURE BIOTECHNOLOGY
- A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies
- (2013) J. Deckert et al. BLOOD
- Tetraspanin CD37 contributes to the initiation of cellular immunity by promoting dendritic cell migration
- (2013) Kate H. Gartlan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antibody Therapeutics in Cancer
- (2013) M. X. Sliwkowski et al. SCIENCE
- Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals
- (2012) Rosa Lapalombella et al. CANCER CELL
- SMIP-016 in Action: CD37 as a Death Receptor
- (2012) Lei Jin et al. CANCER CELL
- A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies
- (2011) K.-H. Heider et al. BLOOD
- Tetraspanins in the immune response against cancer
- (2011) Sharon Veenbergen et al. IMMUNOLOGY LETTERS
- Action of novel CD37 antibodies on chronic lymphocytic leukemia cells
- (2011) G Krause et al. LEUKEMIA
- Design of next-generation protein therapeutics
- (2010) Justin Caravella et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now